Covered Stents vs. Angioplasty for Common Iliac Artery In Stent Restenosis: A Retrospective Comparison

Bekken, Joost A.; Geensen, Roos; Kok, Rosemarijn; Kuijper, M.; Vries, Jean‐Paul P.M. de; Fioole, Bram

doi:10.1016/j.ejvs.2021.10.032

Cited by 4 publications

(2 citation statements)

References 31 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kropman et al reported that the primary clinical patency rate was 88% at 1 year, 62% at 3 years and 38% at 5 years follow-up after balloon angioplasty alone or renewed stent placement in addition to balloon angioplasty for symptomatic iliac ISR 5. On the other hand, Bekken et al have recently reported that covered stents offer better outcomes for common iliac artery ISR than angioplasty alone 6. However, the mechanism of ISR in the peripheral artery has not been fully understood, although several reports have focused on the mechanism of ISR in the coronary artery 7–9.…”

Section: Discussionmentioning

confidence: 99%

Angioscopic and histopathological findings of in-stent restenosis in external iliac artery

2023

View full text Add to dashboard Cite

Little has been reported on the angioscopic and histopathological findings of in-stent restenosis (ISR) in the iliac artery. Here, we report a case of a male patient in his 70s who showed recurrent ISR in the right external iliac artery. We observed the ISR lesions with not only an intravascular ultrasound (IVUS) but also an angioscopy and a biopsy to clarify the mechanism of ISR. These imaging and histopathological findings showed neointimal hyperplasia, and we performed endovascular therapy with covered stent placement to prevent neointimal formation. Not only the IVUS but also the angioscopic and histopathological findings were helpful to clarify the mechanism of ISR and to determine the treatment plan.

show abstract

Section: Discussionmentioning

confidence: 99%

Angioscopic and histopathological findings of in-stent restenosis in external iliac artery

2023

View full text Add to dashboard Cite

show abstract

“…The problem related to common iliac arteries like occlusive atherosclerotic is generally treated endovascularly [1]. Currently, stent implantations are considered the main treatment method for iliac arteries.…”

Section: Introductionmentioning

confidence: 99%

Bilateral Iliac Arteries Stent Compression Following Pelvic Surgery: A Case Report and Review of Literature

Mohammadian

2023

IJCCR

View full text Add to dashboard Cite

Extrinsic compression of iliac arteries stents has been reported from different causes, such as uterine fibroids and orthopedic surgery. Although extrinsic compression of stents in the iliac veins has been widely studied, stent compression in the iliac arteries is less common. Here we presented a case with bilateral common iliac arteries stent compression following pelvic surgery. A patient (65-year-old woman) presented with acute critical right limb ischemia. Computed tomography angiography (CTA) showed occlusion of the right common and external iliac artery, and severe stenosis in the left common iliac artery. In addition, there was evidence of a Brenner tumor originating from the left ovary. The patient underwent endovascular recanalization of the right iliac arteries and bilateral balloon-expandable stent deployment, and the ovarian tumor was removed after three weeks. The control CTA scan showed asymmetric bilateral iliac arteries stent compression more prominent on the right side, then self-expanding stents were implanted bilaterally. In Conclusion although iatrogenic compression of the stent in the iliac artery is rare despite scarcity, it is important to maintain a high index of suspicion in selected cases and choose the proper stent accordingly.

show abstract

A Macrophage Membrane‐Functionalized, Reactive Oxygen Species‐Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management

Qu,

Zhong,

Zhu

et al. 2024

Adv Healthcare Materials

View full text Add to dashboard Cite

Atherosclerosis (AS) management typically relies on therapeutic drug interventions, but these strategies typically have drawbacks, including poor site specificity, high systemic intake, and undesired side effects. The field of cell membrane camouflaged biomimetic nanomedicine offers the potential to address these challenges thanks to its ability to mimic the natural properties of cell membranes that enable enhanced biocompatibility, prolonged blood circulation, targeted drug delivery, and evasion of immune recognition, ultimately leading to improved therapeutic outcomes and reduced side effects. In this study, a novel biomimetic approach was developed to construct the M1 macrophage membrane‐coated nanoprodrug (MM@CD‐PBA‐RVT) for AS management. The advanced MM@CD‐PBA‐RVT nanotherapeutics were proved to be effective in inhibiting macrophage phagocytosis and facilitating the cargo delivery to the activated endothelial cells of AS lesion both in vitro and in vivo. Over the 30‐day period of nanotherapy, MM@CD‐PBA‐RVT was capable of significantly inhibiting the progression of AS, while also maintaining a favorable safety profile. In conclusion, the biomimetic MM@CD‐PBA‐RVT showed promise as feasible drug delivery systems for safe and effective anti‐AS applications.This article is protected by copyright. All rights reserved

show abstract

Covered Stents vs. Angioplasty for Common Iliac Artery In Stent Restenosis: A Retrospective Comparison

Cited by 4 publications

References 31 publications

Angioscopic and histopathological findings of in-stent restenosis in external iliac artery

Angioscopic and histopathological findings of in-stent restenosis in external iliac artery

Bilateral Iliac Arteries Stent Compression Following Pelvic Surgery: A Case Report and Review of Literature

A Macrophage Membrane‐Functionalized, Reactive Oxygen Species‐Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management

Contact Info

Product

Resources

About